MX2022010310A - Métodos de preparación de composiciones de oligonucleótidos utilizando ultrafiltración / diafiltración. - Google Patents
Métodos de preparación de composiciones de oligonucleótidos utilizando ultrafiltración / diafiltración.Info
- Publication number
- MX2022010310A MX2022010310A MX2022010310A MX2022010310A MX2022010310A MX 2022010310 A MX2022010310 A MX 2022010310A MX 2022010310 A MX2022010310 A MX 2022010310A MX 2022010310 A MX2022010310 A MX 2022010310A MX 2022010310 A MX2022010310 A MX 2022010310A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- diafiltration
- ultrafiltration
- oligonucleotide compositions
- oligonucleotide
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 238000011026 diafiltration Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000000108 ultra-filtration Methods 0.000 title abstract 3
- 238000013060 ultrafiltration and diafiltration Methods 0.000 abstract 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 239000012062 aqueous buffer Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000012465 retentate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/313—Phosphorodithioates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
En el presente documento se describen métodos para preparar composiciones que contienen oligonucleótidos. Los métodos de esta descripción implican someter una solución acuosa de un oligonucleótido a ultrafiltración / diafiltración (UF/DF) para formar un retenido que contenga el oligonucleótido, donde la ultrafiltración/diafiltración (UF/DF) se lleva a cabo utilizando una solución de tampón acuosa que contiene una o más sales. También se describen en este documento composiciones que contienen oligonucleótidos obtenidas mediante estos métodos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062979687P | 2020-02-21 | 2020-02-21 | |
| PCT/US2021/018856 WO2021168306A1 (en) | 2020-02-21 | 2021-02-19 | Methods of preparing oligonucleotide compositions using ultrafiltration / diafiltration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022010310A true MX2022010310A (es) | 2023-01-24 |
Family
ID=74870921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022010310A MX2022010310A (es) | 2020-02-21 | 2021-02-19 | Métodos de preparación de composiciones de oligonucleótidos utilizando ultrafiltración / diafiltración. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230116671A1 (es) |
| EP (1) | EP4107261A1 (es) |
| JP (1) | JP2023515485A (es) |
| KR (1) | KR20220156843A (es) |
| CN (1) | CN115997013A (es) |
| AU (1) | AU2021224852A1 (es) |
| BR (1) | BR112022016598A2 (es) |
| CA (1) | CA3168716A1 (es) |
| IL (1) | IL295757A (es) |
| MX (1) | MX2022010310A (es) |
| WO (1) | WO2021168306A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4329923A1 (en) * | 2021-04-30 | 2024-03-06 | Hydranautics | Concentration and diafiltration of oligonucleotides |
| WO2023164631A1 (en) * | 2022-02-25 | 2023-08-31 | Amgen Inc. | Methods of preparing high concentration liquid drug substances |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7074333B2 (en) * | 2001-01-19 | 2006-07-11 | Millipore Corporation | Recovery of linear nucleic acids by salt dilution and/or reduced pressure prior to continuous pressure differential ultrafiltration |
| GB201012418D0 (en) * | 2010-07-23 | 2010-09-08 | Santaris Pharma As | Process |
| BR112015022660A2 (pt) * | 2013-03-14 | 2017-10-31 | Shire Human Genetic Therapies | métodos para a purificação de rna mensageiro |
| ES2923018T3 (es) * | 2013-03-15 | 2022-09-22 | Glaxosmithkline Biologicals Sa | Métodos de purificación de ARN |
| CN107873055B (zh) * | 2015-05-29 | 2021-09-17 | 库瑞瓦格房地产有限公司 | 包括至少一个切向流过滤步骤的产生和纯化rna的方法 |
| EP3658155A4 (en) * | 2017-07-28 | 2021-06-30 | Nogra Pharma Limited | PROCESS FOR THE PREPARATION OF OLIGONUCLEOTIDIC COMPOUNDS |
-
2021
- 2021-02-19 IL IL295757A patent/IL295757A/en unknown
- 2021-02-19 WO PCT/US2021/018856 patent/WO2021168306A1/en unknown
- 2021-02-19 US US17/801,196 patent/US20230116671A1/en active Pending
- 2021-02-19 JP JP2022549837A patent/JP2023515485A/ja active Pending
- 2021-02-19 BR BR112022016598A patent/BR112022016598A2/pt unknown
- 2021-02-19 MX MX2022010310A patent/MX2022010310A/es unknown
- 2021-02-19 AU AU2021224852A patent/AU2021224852A1/en active Pending
- 2021-02-19 EP EP21711447.9A patent/EP4107261A1/en active Pending
- 2021-02-19 KR KR1020227032773A patent/KR20220156843A/ko unknown
- 2021-02-19 CA CA3168716A patent/CA3168716A1/en active Pending
- 2021-02-19 CN CN202180030178.9A patent/CN115997013A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4107261A1 (en) | 2022-12-28 |
| WO2021168306A1 (en) | 2021-08-26 |
| AU2021224852A1 (en) | 2022-10-13 |
| BR112022016598A2 (pt) | 2022-11-08 |
| CA3168716A1 (en) | 2021-08-26 |
| CN115997013A (zh) | 2023-04-21 |
| IL295757A (en) | 2022-10-01 |
| US20230116671A1 (en) | 2023-04-13 |
| KR20220156843A (ko) | 2022-11-28 |
| JP2023515485A (ja) | 2023-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022010310A (es) | Métodos de preparación de composiciones de oligonucleótidos utilizando ultrafiltración / diafiltración. | |
| EG24126A (en) | Method for producing 1-olefins by catalytically splitting 1-alkoxyalkanes | |
| MXPA04011243A (es) | Procedimiento para producir un producto de leche sin lactosa. | |
| MY156760A (en) | Process for manufacturing succinic acid | |
| BR112018010635A2 (pt) | linhagens celulares estáveis para a produção retroviral | |
| MX2017006676A (es) | Concentrado de cerveza o de sidra. | |
| RU2012146077A (ru) | Удаление побочных продуктов реакции и примесей из карамельного красителя и стабильный при хранении концентрат карамельного красителя | |
| MX2022010536A (es) | Aislamiento de proteína de legumbres por ultrafiltración. | |
| MY122894A (en) | Purification of onium hydroxides by electrodialysis | |
| ATE419240T1 (de) | Verfahren zum herstellen von 5-fluor-1,3-dialkyl- 1h-pyrazol-4-carbonsäurefluoriden | |
| NO20074865L (no) | Fremstilling og anvendelse av natriumdiformiat | |
| Nadaf et al. | Decalcification: A Simpler and Better Alternative. | |
| WO2021260041A3 (en) | Method for separation of potato proteins with reduced enzymatic activity from potato fruit juice | |
| PL420099A1 (pl) | Sposób produkcji kwasu alfa-ketoglutarowego (AKG) z jednoskładnikowych roztworów wodnych | |
| WO2021224902A3 (en) | An improved process for the preparation of an aqueous ophthalmic solution of difluprednate | |
| WO2011051433A3 (en) | Process for producing polyamines comprising the enzymatic oxidation of amino alcohols | |
| MX2022012561A (es) | Composiciones y metodos para silenciar la expresion de la subunidad alfa tipo ix dependiente del voltaje del canal de sodio (scn9a). | |
| PH12018501046A1 (en) | Crystals of monovalent cation salt of 3-hydroxyisovaleric acid, and method for producing said crystals | |
| MX2023004714A (es) | Métodos para fabricar derivados de ácido nicotínico. | |
| EP4327881A3 (en) | Processes for the preparation of glasdegib and salt thereof and solid state forms of glasdegib maleate and process for preparation thereof | |
| RU2535226C1 (ru) | Способ изготовления пропиточных олигомеров | |
| WO2019088703A3 (ko) | 선택적 에틸렌의 제조방법 | |
| BR112022012463A2 (pt) | Método para fazer uma composição láctea e composição láctea | |
| PL424606A1 (pl) | Sposób wytwarzania koncentratu do produkcji napoju prozdrowotnego zawierającego związki krzemu, stosowanego jako enterotransporter lub enterosorbent oraz modułowa instalacja do wytwarzania koncentratu | |
| RU2012110236A (ru) | Концентрированный водный раствор амфотерного поверхностно-активного вещества, в частности, бетаина, и способ его получения |